4-3766773-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000683.4(ADRA2C):c.167C>T(p.Ala56Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000097 in 1,546,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000683.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADRA2C | NM_000683.4 | c.167C>T | p.Ala56Val | missense_variant | 1/1 | ENST00000330055.7 | NP_000674.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADRA2C | ENST00000330055.7 | c.167C>T | p.Ala56Val | missense_variant | 1/1 | 6 | NM_000683.4 | ENSP00000386069.2 | ||
ADRA2C | ENST00000509482.1 | c.167C>T | p.Ala56Val | missense_variant | 1/2 | 3 | ENSP00000426268.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151964Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 155180Hom.: 0 AF XY: 0.0000240 AC XY: 2AN XY: 83182
GnomAD4 exome AF: 0.0000100 AC: 14AN: 1394492Hom.: 0 Cov.: 31 AF XY: 0.0000131 AC XY: 9AN XY: 686870
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151964Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74200
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.167C>T (p.A56V) alteration is located in exon 1 (coding exon 1) of the ADRA2C gene. This alteration results from a C to T substitution at nucleotide position 167, causing the alanine (A) at amino acid position 56 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at